PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Biomaterials

• Publication date

  2016-10-01

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1016/j.biomaterials.2016.07.037PMID 27521616PMCID PMC5072177
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Distribution of polymer nanoparticles by convection-enhanced delivery to brain tumors.

  2016cited by this paper
• Epidemiology of gliomas.

  2015cited by this paper
• DNA Nanoparticles: Highly PEGylated DNA Nanoparticles Provide Uniform and Widespread Gene Transfer in the Brain (Adv. Healthcare Mater. 7/2015)

  2015cited by this paper
• Imaging the delivery of brain-penetrating PLGA nanoparticles in the brain using magnetic resonance

  2015cited by this paper
• Gemcitabine Induces Radiosensitization Through Inhibition of RAD51-dependent Repair for DNA Double-strand Breaks.

  2015cited by this paper
• Transport Mechanisms of Squalenoyl-Adenosine Nanoparticles Across the Blood–Brain Barrier

  2015cited by this paper
• Highly PEGylated DNA Nanoparticles Provide Uniform and Widespread Gene Transfer in the Brain

  2015cited by this paper
• Induced clustered nanoconfinement of superparamagnetic iron oxide in biodegradable nanoparticles enhances transverse relaxivity for targeted theranostics

  2013cited by this paper
• Self-assembly of squalene-based nucleolipids: relating the chemical structure of the bioconjugates to the architecture of the nanoparticles.

  2013cited by this paper
• Determination of gemcitabine and its metabolite in extracellular fluid of rat brain tumor by ultra performance liquid chromatography-tandem mass spectrometry using microdialysis sampling after intralesional chemotherapy.

  2013cited by this paper
• Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma

  2013cited by this paper
• A phase I trial of carboplatin administered by convection-enhanced delivery to patients with recurrent/progressive glioblastoma multiforme.

  2012cited by this paper
• A Dense Poly(Ethylene Glycol) Coating Improves Penetration of Large Polymeric Nanoparticles Within Brain Tissue

  2012cited by this paper
• AF03, an alternative squalene emulsion-based vaccine adjuvant prepared by a phase inversion temperature method.

  2012cited by this paper
• Canine model of convection-enhanced delivery of cetuximab-conjugated iron-oxide nanoparticles monitored with magnetic resonance imaging.

  2012cited by this paper
• Convection-enhanced delivery of camptothecin-loaded polymer nanoparticles for treatment of intracranial tumors

  2011cited by this paper
• Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics.

  2011cited by this paper
• EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.

  2010cited by this paper
• Poor drug distribution as a possible explanation for the results of the PRECISE trial.

  2010cited by this paper
• Delivering nanomedicine to solid tumors

  2010cited by this paper
• Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.

  2010cited by this paper
• Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway.

  2010cited by this paper
• Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study.

  2010cited by this paper
• Accelerated Blood Clearance Phenomenon Upon Repeated Injection of PEG-modified PLA-nanoparticles

  2009cited by this paper
• Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme

  2009cited by this paper
• Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts.

  2009cited by this paper
• Freeze-drying of squalenoylated nucleoside analogue nanoparticles.

  2009cited by this paper
• Preclinical Toxicology (Subacute and Acute) and Efficacy of a New Squalenoyl Gemcitabine Anticancer Nanomedicine

  2008cited by this paper
• Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue.

  2008cited by this paper
• Malignant gliomas in adults.

  2008cited by this paper
• Squalenoylation Favorably Modifies the in Vivo Pharmacokinetics and Biodistribution of Gemcitabine in Mice

  2008cited by this paper
• Novel PEGylated Nanoassemblies Made of Self‐Assembled Squalenoyl Nucleoside Analogues

  2008cited by this paper
• Diffusion in brain extracellular space.

  2008cited by this paper
• Dilation and degradation of the brain extracellular matrix enhances penetration of infused polymer nanoparticles.

  2007cited by this paper
• Differential radiosensitizing potential of temozolomide in MGMT promoter methylated glioblastoma multiforme cell lines.

  2007cited by this paper
• Chemoradiotherapy in malignant glioma: standard of care and future directions.

  2007cited by this paper
• Coating thickness of magnetic iron oxide nanoparticles affects R2 relaxivity

  2007cited by this paper
• Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes.

  2006cited by this paper
• Squalenoyl nanomedicines as potential therapeutics.

  2006cited by this paper
• The radiosensitising effect of difluorodeoxyuridine, a metabolite of gemcitabine, in vitro

  2006cited by this paper
• Gemcitabine and radiation therapy in non-small cell lung cancer: state of the art.

  2006cited by this paper
• In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space.

  2006cited by this paper
• Quantifying the Influence of Surface Coatings on Quantum Dot Uptake in Cells

  2005cited by this paper
• Imaging, Distribution, and Toxicity of Superparamagnetic Iron Oxide Magnetic Resonance Nanoparticles in the Rat Brain and Intracerebral Tumor

  2005cited by this paper
• Role of gemcitabine in cancer therapy.

  2005cited by this paper
• The RG2 rat glioma model

  2005cited by this paper
• Neoadjuvant Gemcitabine/treosulfan Chemotherapy for Newly Diagnosed Glioblastoma

  2004cited by this paper
• Effect of pegylation on pharmaceuticals

  2003cited by this paper
• A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.

  2003cited by this paper
• Diffusion parameters of the extracellular space in human gliomas

  2003cited by this paper
• Selective targeting of homologous DNA recombination repair by gemcitabine.

  2003cited by this paper
• Pharmacokinetics of the Carmustine Implant

  2002cited by this paper
• Gemcitabine cytotoxicity of human malignant glioma cells: modulation by antioxidants, BCL-2 and dexamethasone.

  1999cited by this paper
• Extracellular space structure revealed by diffusion analysis.

  1998cited by this paper
• Water diffusion and exchange as they influence contrast enhancement

  1997cited by this paper
• Role of O6-methylguanine-DNA methyltransferase in resistance of human brain tumor cell lines to the clinically relevant methylating agents temozolomide and streptozotocin.

  1996cited by this paper
• Biodegradable long-circulating polymeric nanospheres.

  1994cited by this paper
• Convection-enhanced delivery of macromolecules in the brain.

  1994cited by this paper

• Bioactive polymers as stimulus-responsive anti-metastatic combination agents to treat pancreatic cancer.

  2025cites this paper
• Pretargeted Polymeric Systems for Conducting Chemo-Radiotherapy on Glioblastoma: An Evaluation of the Impact of Nanomedicine Structure on Bioorthogonal Chemistry In Vivo.

  2025cites this paper
• Green Synthesis of Functionalized Gold Nanoparticles: Evaluation of Biopotential, Oxidative Stress, and Genotoxicity in Neuroglioblastoma Cells for Biomedical Applications

  2025cites this paper
• A fluorescent gemcitabine prodrug that follows a nucleoside transporter-independent internalization and bears enhanced therapeutic efficacy with respect to gemcitabine.

  2024cites this paper
• Repurposing gemcitabine for glioblastoma treatment: the role of drug-conjugates and nanoparticles as drug delivery systems

  2024cites this paper
• Gemcitabine-Vitamin E Prodrug-Loaded Micelles for Pancreatic Cancer Therapy

  2024cites this paper
• Recent advances in targeted drug delivery for the treatment of glioblastoma.

  2024cites this paper
• Doxorubicin-loaded liposome-like particles embedded in chitosan/hyaluronic acid-based hydrogels as a controlled drug release model for local treatment of glioblastoma.

  2024cites this paper
• Cancer cell membrane-modified Soluplus® micelles for gemcitabine delivery to pancreatic cancer using a prodrug approach.

  2024cites this paper
• Injectable local drug delivery systems for glioblastoma: a systematic review and meta-analysis of progress to date.

  2023cites this paper
• Recent Advancements and Strategies for Overcoming the Blood–Brain Barrier Using Albumin-Based Drug Delivery Systems to Treat Brain Cancer, with a Focus on Glioblastoma

  2023cites this paper
• Synthesis, Characterization and binding studies of Polymeric Nanoparticles using Gemcitabine Hydrochloride

  2023cites this paper
• Self-assembled lipid–prodrug nanoparticles

  2023cites this paper
• PEGylated nanoassemblies composed of edelfosine and fulvestrant drugs: In vitro antiproliferative effect against breast cancer cells

  2023cites this paper
• Exploring temozolomide encapsulated PEGylated Liposomes and Lyotropic liquid crystals for effective treatment of glioblastoma: in-vitro, cell line, and pharmacokinetic studies.

  2023cites this paper
• A Highly Translatable Dual-arm Local Delivery Strategy To Achieve Widespread Therapeutic Coverage in Healthy and Tumor-bearing Brain Tissues.

  2023cites this paper
• Cathepsin B-responsive prodrugs for cancer-targeted therapy: Recent advances and progress for clinical translation

  2022cites this paper
• Bioscaffold-based study of glioblastoma cell behavior and drug delivery for tumor therapy.

  2021cites this paper
• Development of Polymer-Based Nanoformulations for Glioblastoma Brain Cancer Therapy and Diagnosis: An Update

  2021cites this paper
• Nanoprobe-mediated precise imaging and therapy of glioma.

  2021cites this paper
• Influencing factors and strategies of enhancing nanoparticles into tumors in vivo

  2021cites this paper
• Recent Advances in Lipid-Based Nanosystems for Gemcitabine and Gemcitabine–Combination Therapy

  2021cites this paper
• Poly(anhydride-ester) gemcitabine: Synthesis and particle engineering of a high payload hydrolysable polymeric drug for cancer therapy.

  2020cites this paper
• Anti-recurrence/metastasis and chemosensitization therapy with thioredoxin reductase-interfering drug delivery system.

  2020cites this paper
• Sustained release of lipophilic gemcitabine from an injectable polymeric hydrogel for synergistically enhancing tumor chemoradiotherapy

  2020cites this paper
• Colloidal nanoparticles as pharmaceutical agents

  2020cites this paper
• Nanomedicine to target multidrug resistant tumors.

  2020cites this paper
• Advances in drug delivery technology for the treatment of glioblastoma multiforme.

  2020cites this paper
• Current Perspectives on Therapies, Including Drug Delivery Systems, for Managing Glioblastoma Multiforme.

  2020cites this paper
• Design and characterization of Squalene-Gusperimus nanoparticles for modulation of innate immunity.

  2020cites this paper
• Nanoemulsion adjuvantation strategy of tumor-associated antigen therapy rephrases mucosal and immunotherapeutic signatures following intranasal vaccination

  2020cites this paper
• Nanomedicine Revisited: Next Generation Therapies for Brain Cancer

  2020cites this paper
• Particulate systems for improving therapeutic efficacy of pharmaceuticals against central nervous system-related diseases

  2020cites this paper
• Recent advances and prospects in Gemcitabine drug delivery systems.

  2020cites this paper
• Biomedical Applications of Multifunctional Polymeric Nanocarriers: A Review of Current Literature

  2020cites this paper
• Intratumoral injection of hydrogel-embedded nanoparticles enhances retention in glioblastoma

  2020cites this paper
• Drug targeting strategies into the brain for treating neurological diseases.

  2019cites this paper
• Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma.

  2019cites this paper
• Convection Enhanced Delivery of Anti-angiogenic and Cytotoxic Agents in Combination Therapy against Brain Tumour.

  2019cites this paper
• A unique multidrug nanomedicine made of squalenoyl-gemcitabine and alkyl-lysophospholipid edelfosine.

  2019cites this paper
• Enhanced γ-Glutamyltranspeptidase Imaging That Unravels the Glioma Recurrence in Post-radio/Chemotherapy Mixtures for Precise Pathology via Enzyme-Triggered Fluorescent Probe

  2019cites this paper
• Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.

  2019cites this paper
• Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy

  2019cites this paper
• Squalene-PEG: Pyropheophorbide-a nanoconstructs for tumor theranostics.

  2019cites this paper
• Seek and destroy: improving PK/PD profiles of anticancer agents with nanoparticles

  2018cites this paper
• Gemcitabine Delivery and Photodynamic Therapy in Cancer Cells via Porphyrin‐Ethylene‐Based Periodic Mesoporous Organosilica Nanoparticles

  2018cites this paper
• Evaluation of lauroyl-gemcitabine-loaded hydrogel efficacy in glioblastoma rat models.

  2018cites this paper
• Tween 80-modified hyaluronic acid-ss-curcumin micelles for targeting glioma: Synthesis, characterization and their in vitro evaluation.

  2018cites this paper
• Simultaneous quantification of Gemcitabine and Irinotecan hydrochloride in rat plasma by using high performance liquid chromatography‐diode array detector

  2018cites this paper
• Biodegradable PEG-poly(ω-pentadecalactone-co-p-dioxanone) nanoparticles for enhanced and sustained drug delivery to treat brain tumors.

  2018cites this paper
• Convection enhanced delivery of chemotherapeutic drugs into brain tumour

  2018cites this paper
• Striking a Balance between Carbonate/Carbamate Linkage Bond- and Reduction-Sensitive Disulfide Bond-Bearing Linker for Tailored Controlled Release: In Situ Covalent-Albumin-Binding Gemcitabine Prodrugs Promote Bioavailability and Tumor Accumulation.

  2018cites this paper
• Redox-responsive PEGylated self-assembled prodrug-nanoparticles formed by single disulfide bond bridge periplocymarin-vitamin E conjugate for liver cancer chemotherapy

  2017cites this paper
• Nanomaterials for convection-enhanced delivery of agents to treat brain tumors.

  2017cites this paper
• Paclitaxel loaded phospholipid-based gel as a drug delivery system for local treatment of glioma.

  2017cites this paper
• Design, Preparation and Characterization of Modular Squalene-based Nanosystems for Controlled Drug Release.

  2017cites this paper
• 4.30 Nanomaterials for Drug Delivery to the Brain

  2017cites this paper
• Targeted and theranostic applications for nanotechnologies in medicine

  2017cites this paper
• Diels Alder-mediated release of gemcitabine from nanoparticles : developing improved methods for pancreatic cancer drug delivery

  2017cites this paper
• Gemcitabine and glioblastoma: challenges and current perspectives.

  2017cites this paper
• Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection

  2017cites this paper
• Local DNA Repair Inhibition for Sustained Radiosensitization of High-Grade Gliomas

  2017cites this paper